Daiichi Sankyo
Japanese pharmaceutical giant leading in antibody-drug conjugates (ADCs)
Signal history
2 totalDaiichi Sankyo Europe Partners with Gaia on Digital Cholesterol Therapeutic
Daiichi Sankyo's European division is teaming up with German medtech Gaia to sell the latter company's cardiovascular digital therapeutic.
Daiichi Sankyo Opens Toronto HQ to Boost Oncology R&D
Daiichi Sankyo has further established its presence in Canada with the official opening of its new head office in the Greater Toronto Area.
Key Changes (30d)
Daiichi Sankyo and GAIA join forces to commercialise digital therapeutic for high cholesterol
Daiichi Sankyo Europe partners with Gaia to commercialize a digital therapeutic for high cholesterol, expanding into the digital health market.
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Daiichi Sankyo opens new Toronto headquarters to accelerate global oncology R&D, potentially boosting drug development and market entry.
Source Language Distribution
Language distribution will appear as more signals are collected from diverse sources.
Strategic themes and signal pattern
Strategic Themes
Recent Signal Pattern
Industry Peer Comparison
Why this company matters
Daiichi Sankyo's ADC platform has established Japan as a global leader in next-generation cancer therapeutics, with a pipeline valued at tens of billions of dollars.
- Key domain relevance: Antibody-Drug Conjugates, Oncology, Rare Diseases
- Active monitoring with 2 signals in the last 30 days across 7 tracked sources.
Channel Context
Daiichi Sankyo is a key company within the Healthtech & Biotech channel. Its official updates regularly contribute to how users track developments in this space.
View channelMarket Context
This company operates in one of SigFact's strongest advantage markets, where official updates often surface first in local language.
See recent signals in this marketPeers and related companies
All companiesAstellas Pharma
Adv. marketMajor Japanese pharma company focused on urology, oncology, and transplantation
AstraZeneca
Anglo-Swedish pharma company with strong oncology and rare disease pipeline
BeiGene
Adv. marketChina's largest global biotech company focused on innovative oncology medicines
Biocon
India's largest biopharmaceutical company and global biosimilars leader
Biofourmis
Digital therapeutics and remote patient monitoring platform
CSL Limited
Global biotech leader in plasma-derived therapies and vaccines
Continue monitoring Daiichi Sankyo
Follow this company, add it to your watchlist, or explore its signal stream to stay informed.